Skip to main content

Patrik Hammarén appointed as President of Nokia Technologies

Nokia Corporation Stock Exchange Release22 January 2025 at 08:00 EET Patrik Hammarén appointed as President of Nokia TechnologiesPatrik Hammarén appointed as President of Nokia Technologies and member of the Nokia Group Leadership TeamEspoo, Finland – Nokia today announced the appointment of Patrik Hammarén as President of Nokia Technologies and member of the Nokia Group Leadership Team, effective 22 January 2025. Nokia Technologies is responsible for managing and monetizing Nokia’s intellectual property, including the company’s industry leading patent portfolio. The business group licenses Nokia’s innovation and contributions to global technology standards to other companies. Hammarén joined Nokia in 2007 and has been acting President of Nokia Technologies since October 2024. Prior to this role, Patrik held several senior positions...

Continue reading

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myelomaApproval is based on positive results from the IMROZ phase 3 study, demonstrating Sarclisa in combination with standard-of-care treatment significantly improved PFS, compared to the standard of care alone in TI NDMM Represents third indication in the EU, including two for the treatment of adult patients with R/R MM, and one in NDMMParis, January 22, 2025. Following the adoption of a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly diagnosed...

Continue reading

Nasdaq Report Identifies Between $25 Billion and $50 Billion in Potential Efficiency Gains in Banks’ Risk and Compliance Functions

The savings, which would come at greater or equal effectiveness, could generate up to $1 trillion in additional lending capacity DAVOS, Switzerland, Jan. 22, 2025 (GLOBE NEWSWIRE) — Between $25 billion and $50 billion in potential efficiency gains can be realized through targeted enhancements in banks’ Risk and Compliance functions alone without compromising effectiveness, according to a report released by Nasdaq and Boston Consulting Group (BCG). The report, titled “The New Growth Imperative: Cutting through Complexity in the Financial System” reviews the interconnected challenge of complexity and complicatedness and finds that while external complexity continues to increase, excess layers of internal complicatedness have accumulated. “Financial institutions are particularly exposed to the exponential growth in complexity...

Continue reading

Sandfire America Announces New Board Member

WHITE SULPHUR SPRINGS, Mont., Jan. 21, 2025 (GLOBE NEWSWIRE) — Sandfire Resources America Inc. (“Sandfire America” or the “Company“) announces that Gemma Tually has been appointed to the Sandfire America Board of Directors effective immediately. This occurs in conjunction with Victoria Twiss stepping down from her seat on the Board. Ms. Tually is the Chief Legal & Compliance Officer for Sandfire Resources Ltd. (Australia); 86.9% owner of Sandfire America’s outstanding shares. Ms. Tually is a qualified solicitor with more than 20 years of legal experience working across areas including mining, dispute resolution, international trade and transport, finance, and corporate law. The Company welcomes Ms. Tually to the SFR Board and extends its sincere thanks to Ms. Twiss for her contributions to the Board...

Continue reading

EHang Launches UAM Exhibition (Experience) Center in Shenzhen’s Luohu District, Showcasing First Automated Smart eVTOL Vertiport for EH216-S

GUANGZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Urban Air Mobility (“UAM”) technology platform company, announced the launch of its Exhibition (Experience) Center in Shenzhen’s Luohu Sports and Leisure Park. It is the world’s first EH216-S takeoff and landing site featuring a fully automated vertical lift vertiport. It also marks a new smart infrastructure in Shenzhen dedicated to the commercial operations of the EH216-S pilotless passenger-carrying aerial vehicle, establishing a groundbreaking model for electric vertical takeoff and landing (“eVTOL”) aircraft operations in urban areas.(Image: The Luohu UAM Exhibition (Experience) Center) The Luohu UAM Center, designed by EHang, boasts an automated three-dimensional vertical lift vertiport....

Continue reading

Tactical Resources Corp. Announces Closing of Debenture Offering

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — Tactical Resources Corp. (TSXV: RARE) (OTC: USREF) (“Tactical Resources” or the “Company”) is pleased to announce that the Company has completed a non-brokered private placement of unsecured convertible debentures (the “Debentures”) in the principal amount of $500,000 with certain third-party lenders (the “Private Placement”). The Debentures have a maturity date of January 21, 2027 (the “Maturity Date”) and may be converted into units of the Company (the “Units”) at any time from the date of issuance until the Maturity Date, at a conversion price of $0.20 per Unit (the “Conversion...

Continue reading

LanzaTech to Form New Joint Venture and Launch Spin-Out of LanzaX Business, and Appoints Interim CFO of LanzaTech

Announces intent to spin out and form a growth-oriented joint venture for LanzaX, the Company’s differentiated synthetic biology platform, with Tharsis Capital joining as new LanzaX strategic partner to accelerate financing for the synbio development pipeline Appoints new Interim Chief Financial Officer of LanzaTech to streamline biorefining platform growth priorities and heighten focus on cost reductions CHICAGO, Jan. 21, 2025 (GLOBE NEWSWIRE) — LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or “the Company”), the carbon recycling company transforming waste carbon into sustainable fuels, chemicals, materials, and protein, today announced its intent to form LanzaX, a business unit dedicated to its wholly-owned synthetic biology platform. LanzaTech intends to spin out LanzaX from its core biorefining business as a joint venture...

Continue reading

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced today announced it has entered into agreements with certain holders of its existing warrants exercisable for 4,971,110 shares of its common stock, in the aggregate, to exercise outstanding warrants at a reduced exercise price of $0.751 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $3.7 million, before deducting financial advisory fees. The exercisability of the new warrants and any resulting issuance of the shares underlying the new warrants are subject to...

Continue reading

Toppoint Holdings Inc. Announces Pricing of $10 Million Initial Public Offering

NORTH WALES, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) — Toppoint Holdings Inc. (“Toppoint” or the “Company”) today announced the pricing of its initial public offering of an aggregate of 2,500,000 shares of its common stock (the “Shares”), all of which are being offered by Toppoint at a public offering price of $4.00 per share (the “Offering”), for aggregate gross proceeds of $10 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock at the initial public offering price, representing 15% of the Shares sold in the Offering, less underwriting discounts and commissions, to cover over-allotments. The Offering is expected to close on or about January 23, 2025, subject to satisfaction...

Continue reading

HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets

VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ: SNDL) (“SNDL“), one of the world’s largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridges. Leveraging HYTN’s GMP-certified facility and expertise in quality system development, SNDL will provide specialized equipment, cannabis consumables, and the required capital to meet stringent regulatory requirements for GMP product development. HYTN will endeavour to amend its licenses and/or certificates, establish a stability...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.